Invention Grant
- Patent Title: Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
-
Application No.: US15600942Application Date: 2017-05-22
-
Publication No.: US09833457B2Publication Date: 2017-12-05
- Inventor: Adnan M. M. Mjalli , Bapu Gaddam , Dharma Rao Polisetti , Matthew J. Kostura , Mustafa Guzel
- Applicant: vTv Therapeutics LLC
- Applicant Address: US NC High Point
- Assignee: vTv Therapeutics LLC
- Current Assignee: vTv Therapeutics LLC
- Current Assignee Address: US NC High Point
- Agent Samuel B. Rollins
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D471/04
Abstract:
The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to psoriatic arthritis.
Public/Granted literature
- US20170252343A1 TRICYCLIC COMPOUNDS AS MODULATORS OF TNF-ALPHA SYNTHESIS AND AS PDE4 INHIBITORS Public/Granted day:2017-09-07
Information query
IPC分类:
